|
1
|
Ross DT, Scherf U, Eisen MB, et al:
Systematic variation in gene expression patterns in human cancer
cell lines. Nat Genet. 24:227–235. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ellison G, Klinowska T, Westwood RF,
Docter E, French T and Fox JC: Further evidence to support the
melanocytic origin of MDA-MB-435. Mol Pathol. 55:294–299. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rae JM, Ramus SJ, Waltham M, et al: Common
origins of MDA-MB-435 cells from various sources with those shown
to have melanoma properties. Clin Exp Metastasis. 21:543–552.
2004.PubMed/NCBI
|
|
4
|
You H, Yu W, Sanders BG and Kline K:
RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human
breast cancer cells to undergo differentiation. Cell Growth Differ.
12:471–480. 2001.PubMed/NCBI
|
|
5
|
Bachmeier BE, Nerlich AG, Lichtinghagen R
and Sommerhoff CP: Matrix metalloproteinases (MMPs) in breast
cancer cell lines of different tumorigenicity. Anticancer Res.
21:3821–3828. 2001.PubMed/NCBI
|
|
6
|
Sellappan S, Grijalva R, Zhou X, et al:
Lineage infidelity of MDA-MB-435 cells: expression of melanocyte
proteins in a breast cancer cell line. Cancer Res. 64:3479–3485.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bachmeier BE, Nerlich AG, Mirisola V,
Jochum M and Pfeffer U: Lineage infidelity and expression of
melanocytic markers in human breast cancer. Int J Oncol.
33:1011–1015. 2008.PubMed/NCBI
|
|
8
|
Bachmeier BE, Albini A, Vene R, et al:
Cell density-dependent regulation of matrix metalloproteinase and
TIMP expression in differently tumorigenic breast cancer cell
lines. Exp Cell Res. 305:83–98. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bachmeier BE, Rohrbach H, De Waal J,
Jochum M and Nerlich AG: Enhanced expression and activation of
major matrix metalloproteinases in distinct topographic areas of
invasive breast carcinomas. Int J Oncol. 26:1203–1207.
2005.PubMed/NCBI
|
|
10
|
Bachmeier BE, Vene R, Iancu CM, et al:
Transcriptional control of cell density dependent regulation of
matrix metalloproteinase and TIMP expression in breast cancer cell
lines. Thromb Haemost. 93:761–769. 2005.PubMed/NCBI
|
|
11
|
Price JE, Polyzos A, Zhang RD and Daniels
LM: Tumorigenicity and metastasis of human breast carcinoma cell
lines in nude mice. Cancer Res. 50:717–721. 1990.PubMed/NCBI
|
|
12
|
Zhang RD, Fidler IJ and Price JE: Relative
malignant potential of human breast carcinoma cell lines
established from pleural effusions and a brain metastasis. Invasion
Metastasis. 11:204–215. 1991.
|
|
13
|
Rozen S and Skaletsky H: Primer3 on the
WWW for general users and for biologist programmers. Methods Mol
Biol. 132:365–386. 2000.PubMed/NCBI
|
|
14
|
Muller PY, Janovjak H, Miserez AR and
Dobbie Z: Processing of gene expression data generated by
quantitative real-time RT-PCR. Biotechniques. 32:1372–1379.
2002.PubMed/NCBI
|
|
15
|
Soule HD, Vazguez J, Long A, Albert S and
Brennan M: A human cell line from a pleural effusion derived from a
breast carcinoma. J Natl Cancer Inst. 51:1409–1416. 1973.PubMed/NCBI
|
|
16
|
Cailleau R, Olive M and Cruciger QV:
Long-term human breast carcinoma cell lines of metastatic origin:
preliminary characterization. In Vitro. 14:911–915. 1978.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moll R: Molecular diversity of
cytokeratins: significance for cell and tumor differentiation. Acta
Histochem Suppl. 41:117–127. 1991.PubMed/NCBI
|
